TERSI
TERSI Hydrating Topical Foam
(selenium sulfide in a water and lipid based foam, 2.25%)
DESCRIPTION
CHEMICAL STRUCTURE
Selenium sulfide has the following chemical structure:
CLINICAL PHARMACOLOGY
PHARMACOKINETICS
INDICATIONS AND USAGE
CONTRAINDICATIONS
WARNINGS
PRECAUTIONS
Pregnancy (Category C)
Nursing Mothers
ADVERSE REACTIONS
DOSAGE AND ADMINISTRATION
TERSI should be shaken vigorously before each application and inverted to administer.
HOW SUPPLIED
TERSI is supplied in a 70 gram or 2.5 ounce aerosolized canister bearing the NDC Number 23710-225-70 and a 10 gram or 0.36 ounce aerosolized canister bearing the NDC Number 23710-025-01. The 10 gram canister is physician dispensed sample product.
Store at controlled room temperature 15º - 25ºC (59º - 77ºF).
Contains flammable materials. Contents under pressure. Do not puncture or incinerate. Do not expose to temperatures over 120ºF [48ºC] even when empty. Keep out of reach of children.
TERSI is covered by U.S. Patent 5,993,830.
TERSI is manufactured for Quinnova Pharmaceuticals, Inc., Newtown, PA 18940, (877) 6606263, www.QUINNOVA.com.
Prescribing Information as of September2007.
TRSFO025 7/08